PGEN
Biotechnology · Healthcare
COO
Equibles does not estimate personal net worth.
Get an email with a short summary when Precigen, Inc. publishes a filing, an earnings call transcript or a press release.
Get PGEN alertsRutul Shah is recorded as COO at Precigen, Inc. (PGEN). The proxy statement of Precigen, Inc. reports total compensation of $1,560,912 for Rutul Shah in fiscal 2025, including a base salary of $485,000. Disclosed compensation is on record for 4 fiscal years. Rutul Shah has spoken on 2 earnings calls across 1 company, most recently for Precigen, Inc. on November 13, 2025. Precigen, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Precigen, Inc. includes Helen Sabzevari (CEO and Board Member), Helen Sabzevari, Ph.D. (CEO), Randal J. Kirk (Chairman and Board Member) and 7 others.
“I'm excited to share Papcemias manufacturing operations updates today. As part of our strategic commitment to long-term value creation, we have made significant investments to help control over our cGMP manufacturing operations.”
“I would like to take a few moments to discuss our manufacturing strategy and provide an update. As you are aware, we have made significant commitment and investment to be in control of our GMP manufacturing activities.”
PGEN
Biotechnology · Healthcare
COO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Precigen, Inc. (PGEN) | Chief Operating Officer | $485,000 | $1,560,912 |
| 2024 | Precigen, Inc. (PGEN) | Chief Operating Officer | $452,116 | $1,407,544 |
| 2023 | Precigen, Inc. (PGEN) | Chief Operating Officer | $410,000 | $1,037,974 |
| 2022 | Precigen, Inc. (PGEN) | Chief Operating Officer | $327,500 | $793,083 |